IncidenceRisk FactorsFollow-Up StudiesCohort StudiesRetrospective StudiesProspective StudiesTreatment OutcomeNeoplasms, Second PrimaryTime FactorsProportional Hazards ModelsRecurrenceGraft vs Host DiseaseTransplantation ConditioningSurvival AnalysisTransplantation, HomologousHematopoietic Stem Cell TransplantationKaplan-Meier EstimateHematologic NeoplasmsRisk AssessmentSurvival RateDisease-Free SurvivalCord Blood Stem Cell TransplantationRegistriesRiskAge DistributionMinnesotaWisconsinInfant, NewbornPrognosisMultivariate AnalysisUnited StatesPrevalenceAge FactorsSwedenVidarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaDisease ProgressionImmunosuppressive AgentsLife TablesUnrelated DonorsJapanCombined Modality TherapyTissue DonorsNeoplasm Recurrence, LocalSurvivorsBusulfanAntilymphocyte SerumMyeloablative AgonistsSex DistributionLongitudinal StudiesPoisson DistributionDenmarkSiblingsPopulation SurveillanceBreast NeoplasmsModels, StatisticalNeoplasmsRadiotherapyPostoperative ComplicationsRemission InductionAcute DiseaseBone Marrow TransplantationConfidence IntervalsMyelodysplastic SyndromesOdds RatioNeoplasms, Radiation-InducedWhole-Body IrradiationLeukemia, Myeloid, AcuteHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsOsteonecrosisPeripheral Blood Stem Cell TransplantationTreatment FailureDiabetes Mellitus, Type 1HistocompatibilitySirolimusTaiwanNetherlandsGraft SurvivalUterine Cervical NeoplasmsEpidemiologic MethodsAge of OnsetRegression AnalysisRadiotherapy DosagePredictive Value of TestsTacrolimusScandinaviaMastectomy, SegmentalCause of DeathItalyAnemia, AplasticLogistic ModelsChronic DiseaseInfectionComorbidityMyocardial InfarctionKidney Failure, ChronicCranial IrradiationLeukemiaRadiotherapy, Adjuvant